Yi Ba
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Extracellular vesicles in disease
- RNA Interference and Gene Delivery
- Circular RNAs in diseases
Papers in
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 2
- Cancer, Hypoxia, and Metabolism 2
-
- Extracellular vesicles in disease 5
- Peroxisome Proliferator-Activated Receptors 2
- RNA Interference and Gene Delivery 2
- Co-authors
- Haiyang Zhang (7 shared papers)Ting Deng (5 shared papers)Guoguang Ying (4 shared papers)Claudia Chiodoni (1 shared paper)Ralph A. Reisfeld (1 shared paper)Noriko Mizutani (1 shared paper)Rong Xiang (1 shared paper)He Zhou (1 shared paper)
- Journals
- Cancer Research (2 papers)International Journal for Parasitology Parasites and Wildlife (1 paper)Journal of Clinical Oncology (1 paper)Materials Characterization (1 paper)Annals of Oncology (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Yi Ba
21 papers receiving 664 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 268
- Molecular Biology 441
- Immunology 108
- Biotechnology 39
- Oncology 78
Countries citing papers authored by Yi Ba
This map shows the geographic impact of Yi Ba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ba more than expected).
Fields of papers citing papers by Yi Ba
This network shows the impact of papers produced by Yi Ba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ba. The network helps show where Yi Ba may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Ba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 141 | |
| 2 | 2018 | 110 | |
| 3 | 2021 | 93 | |
| 4 | 2007 | 91 | |
| 5 | 2019 | 56 | |
| 6 | 2021 | 54 | |
| 7 | 2018 | 51 | |
| 8 | 2017 | 28 | |
| 9 | 2019 | 12 | |
| 10 | 2021 | 10 | |
| 11 | 2024 | 9 | |
| 12 | 2011 | 5 | |
| 13 | 2025 | 3 | |
| 14 | Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer | 2020 | 2 |
| 15 | 2024 | 2 | |
| 16 | 2025 | 2 | |
| 17 | MIG(CXCL9)ケモカイン遺伝子療法と抗体-サイトカイン融合蛋白質の併用はマウス結腸癌の増殖と播種を抑制する | 2001 | 1 |
| 18 | 2022 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2025 | 1 |
About Yi Ba
Yi Ba is a scholar working on Cancer Research, Molecular Biology, Oncology, Materials Chemistry and Geriatrics and Gerontology, having authored 27 papers that have together received 674 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (5 papers), Shape Memory Alloy Transformations (4 papers), MicroRNA in disease regulation (4 papers), High Entropy Alloys Studies (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Cancer-related molecular mechanisms research (2 papers), RNA Interference and Gene Delivery (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (268 citations), Molecular Biology (441 citations), Immunology (108 citations), Biotechnology (39 citations) and Oncology (78 citations). Yi Ba has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Haiyang Zhang, Ting Deng, Guoguang Ying, Claudia Chiodoni, Ralph A. Reisfeld, Noriko Mizutani, Rong Xiang, He Zhou, Jürgen Christian Becker and Yunping Luo. Their work appears in journals such as Cancer Research, International Journal for Parasitology Parasites and Wildlife, Journal of Clinical Oncology, Materials Characterization and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.